πŸ‡ΊπŸ‡Έ FDA
Patent

US 7893022

Anti-angiogenic methods and compositions

granted A61KA61K38/00A61P

Quick answer

US patent 7893022 (Anti-angiogenic methods and compositions) held by Sangamo Biosciences, Inc. expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61P, A61P27/02, A61P35/00